InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Kearns Evan. Director active across 1 company, notably Cogent Biosciences, Inc.. Cumulatively, 2 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €2.1m. Activity tracked since 17 December 2025. The latest transaction was filed on 26 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations